INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
07/29/2025
Back to search
Official data from USPTO
LETIFEND
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
07/30/2025
Classification
Registered
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
12/07/2016
Registration date
05/15/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/29/2024
Last transaction
07/30/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
ES
Examiner
FOSDICK, GEOFFREY
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized term "LETIFEND" with the letters "L","E","T","I" appearing in the color blue, and the dot of the "I" and the letters "F","E","N","D" appearing in the color gray.
Holders and representatives
Holders
LETI Pharma, S.L.U.
LABORATORIOS LETI, S.L. UNIPERSONAL
Representatives
Elizabeth Lee Lucas & Mercanti, LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
chemicals used in industry; chemical preparations for scientific purposes, other than for medical or veterinary use
Class 5
Pharmaceutical and veterinary products, namely, vaccines; Dietetic foods and beverages adapted for medical purposes and dietary supplements; food for babies; dietary supplements for animals; sanitary articles and preparations, namely, antibacterial skin soaps and antibacterial hand lotions; feminine hygiene pads; baby diapers and incontinence diapers; products and preparations for pest control, namely, pesticides; medicinal and veterinary products and preparations, namely, vaccines; implants comprising living tissue for surgical purposes; diagnostic preparations for medical or veterinary purposes; pharmaceutical preparations for use in the treatment of bacterial, parasitic, viral and infectious diseases; wound dressings, bandages for skin wounds
Class 42
Information technology consulting services; development, programming and implementation of computer software for others; development of computer hardware equipment; computer software rental and server hosting services; rental of computer hardware and computer peripherals; computer software consultation; computer security consultancy; media duplication of data and digital information; data conversion of electronic information and data encryption services; scientific research; medical research; consultancy pertaining to pharmacology; architectural consultation and urban design planning services; technical consultation in the field of environmental science, engineering services, design for others in the field of energy engineering, designing and testing of energy products for others; geological research; quality control for others; new product design services
Publications
History of USPTO decisions and trademark events.
36 publications found
C71T
CANCELLED SECTION 71
11/29/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/15/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/16/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/15/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/24/2018
FIMP
FINAL DISPOSITION PROCESSED
08/24/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/15/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
05/15/2018
GPNX
NOTIFICATION PROCESSED BY IB
03/09/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/27/2018
PUBO
PUBLISHED FOR OPPOSITION
02/27/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/21/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/21/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/07/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/19/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/19/2018
CNEA
EXAMINERS AMENDMENT MAILED
01/19/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/19/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
01/19/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/19/2018
CNFR
FINAL REFUSAL MAILED
01/02/2018
CNFR
FINAL REFUSAL WRITTEN
01/02/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/26/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/26/2017
ALIE
ASSIGNED TO LIE
12/21/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/14/2017
RFNT
REFUSAL PROCESSED BY IB
08/18/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/30/2017
RFRR
REFUSAL PROCESSED BY MPU
07/29/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/27/2017
CNRT
NON-FINAL ACTION WRITTEN
07/26/2017
MAFR
APPLICATION FILING RECEIPT MAILED
07/25/2017
DOCK
ASSIGNED TO EXAMINER
07/21/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/21/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/20/2017
Continuous trademark protection
Get notified about every new filing that threatens LETIFEND or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.